Cost effectiveness of screening for intracranial aneurysms among patients with bicuspid aortic valve: a Markov modelling study.

Cost effectiveness of screening for intracranial aneurysms among patients with bicuspid aortic valve: a Markov modelling study.
复制标题

二叶式主动脉瓣患者颅内动脉瘤筛查的成本效益:马尔可夫模型研究

DOI:
10.1136/bmjopen-2021-051236
复制
发表时间:
2021-12-14
期刊:
影响因子:
2.9
通讯作者:
Liu A
Liu A
中科院分区:
医学3区
文献类型:
--
作者:
Chen J;Han M;Feng X;Peng F;Tong X;Niu H;Zhang D;Liu A

文献摘要

参考文献

相似文献

Bicuspid aortic valve (BAV) is common and 7.7%–9.8% of patients with BAV have intracranial aneuryms (IAs) which might lead to a devastating subarachnoid haemorrhage (SAH). We aimed to evaluate different screening and follow-up strategies using magnetic resonance angiography for IAs among patients with BAV. A decision-analytic model was built to evaluate the costs and effectiveness of different management strategies from the Chinese healthcare payer’s perspective. The evaluated strategies included natural history without screening for possible IAs, regular screening and no follow-up for detected IAs, and regular screening with regular follow-up (Screen strategy/Follow-up strategy). Base case calculation, as well as probabilistic, one-way, and two-way sensitivity analyses, were performed. According to the base case calculation, natural history had the least cost and effectiveness while Every 5 years (y)/Annual gained the highest cost and effectiveness. Every 10y/Biennial was cost effective when compared with Every 10y/Every 5y under the willingness-to-pay threshold of ¥211 743 (US$30 162). Probabilistic sensitivity analysis showed that Every 10y/Biennial was superior in 88.3% of the cases when compared with Every 10y/Every 5y. One-way and two-way sensitivity analyses proved that Every 10y/Biennial was the dominant strategy under most circumstances. Screening for possible IAs among patients with BAV and follow-up for detected IAs would increase the effectiveness. Every 10y/Biennial was the optimal strategy from the Chinese healthcare payer’s perspective.
DOI: 10.1177/0272989x12458348
发表时间: 2012-09-01
影响因子: 3.6
作者:
Briggs, Andrew H.;Weinstein, Milton C.;Paltiel, A. David
通讯作者: Paltiel, A. David
DOI: 10.1016/s1474-4422(09)70126-7
发表时间: 2009-07-01
期刊: LANCET NEUROLOGY
影响因子: 48
作者:
Nieuwkamp, Dennis J.;Setz, Larissa E.;Rinkel, Gabriel E.
通讯作者: Rinkel, Gabriel E.
DOI: 10.1016/j.kint.2017.08.016
发表时间: 2018-03-01
影响因子: 19.6
作者:
Flahault, Adrien;Trystram, Denis;Joly, Dominique
通讯作者: Joly, Dominique
DOI: 10.4103/2152-7806.170029
发表时间: 2015
影响因子: --
作者:
Rustemi O;Alaraj A;Shakur SF;Orning JL;Du X;Aletich VA;Amin-Hanjani S;Charbel FT
通讯作者: Charbel FT